Tens of billions of antithrombotic drugs have fallen into the "Altar"! TOP10 rankings have changed, Yangzijiang and others will be the first to imitate

A few days ago, Yangtze River Jiangsu Zilong Pharmaceutical's Fondaparinux Sodium Injection was approved as a supplementary application, and it is the fourth company that has reviewed the product

Soaring 130% injections, Yangtze River commented! The 30 billion market makes waves again

Sales of Fondaparinux Sodium Injection in Public Medical Institutions in China (Unit: 100 million yuan)

Source: Mi Nei.

A few days ago, Yangtze River Jiangsu Zilong Pharmaceutical's Fondaparinux Sodium Injection was approved as a supplementary application, and it is the fourth company that has reviewed the product

Up to now, Yangtze River has already reviewed 4 antithrombotic drugs.

Sales of terminal antithrombotic drugs in public medical institutions in China

Source: Mi Nei.

In addition to Yangtze River, Changzhou Pharmaceutical's rivaroxaban tablets and Beijing Baiao's apixaban tablets have all entered administrative approvals and are expected to be approved.

From the perspective of TOP10 manufacturers, the top three are foreign-funded pharmaceutical companies.

Tens of billions of antithrombotic drugs fell into the "Altar"! TOP10 ranking changes

2021H1 TOP10 Terminal Antithrombotic Drug Products in China's Public Medical Institutions

Source: Mi Nei.

Among the TOP10 products, the top five have sales of more than 1 billion yuan.

2021H1 China's top 10 public medical institutions' terminal antithrombotic drug brands

Source: Mi Nei.

In the TOP10 brands, Bayer and Sanofi each have two brands on the list.

Sales of Clopidogrel Bisulfate Tablets in China's Public Medical Institutions (Unit: 100 million yuan)

Source: Mi Nei.

Up to now, the five batches of national procurement have a total of 6 antithrombotic tablets, clopidogrel bisulfate tablets, apixaban tablets, ticagrelor tablets, bivacrudine for injection, dabigatran etexilate capsules, and rivaroxaban tablets.

Three major products became "Fragrant Pastry", Nanjing Chia Tai Tianqing, Yangtze River.

Source: Meinenet MED2.

Since the beginning of this year, a total of 10 antithrombotic drugs have been approved for marketing.
Among them, rivaroxaban tablets have the largest number of approved companies, with 19 companies, followed by ticagrelor tablets with 11 and apixaban tablets with 10
.
In addition, Wuhan Hengxinyuan Pharmaceutical's ozagrel tromethamine injection concentrated solution was approved as a new drug category 2.
1, and it was the first domestically produced enterprise of the product; Tianjin Hongri Pharmaceutical's sagogrelide hydrochloride tablets was the "first imitation".
+The first review"
.

Antithrombotic drugs under review for production from 2021 to present

Source: Meinenet MED2.
0 Chinese Drug Evaluation Database

There are 23 antithrombotic drugs submitted for production and are under review and approval, with more than 80 acceptance numbers
.
Among them, Argatroban injection and rivaroxaban tablets are the most sought-after, with 9 companies each
.
In addition, clopidogrel bisulfate aspirin tablets and prasugrel hydrochloride tablets have not been approved by domestic companies, and 4 such as idoxaban tosylate tablets, selepag tablets and ticagrelor dispersible tablets have no generic drugs.
Approved, involving Nanjing Chia Tai Tianqing Pharmaceutical, Jiangsu Haosen Pharmaceutical Group, Yangtze River Pharmaceutical Group Guangzhou Hairui Pharmaceutical and other companies
.

Source: Mi Nei Net Database

If there are any errors or omissions, please correct me
.